-
公开(公告)号:US20060025570A1
公开(公告)日:2006-02-02
申请号:US11169232
申请日:2005-06-28
申请人: Katherine Turner , Steven Clark , Kenneth Jacobs , Rodney Hewick , Thomas Gesner
发明人: Katherine Turner , Steven Clark , Kenneth Jacobs , Rodney Hewick , Thomas Gesner
IPC分类号: A61K38/18 , C07K14/475
摘要: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
摘要翻译: 人类巨核细胞刺激因子(MSF)的新型多肽。 提供含有它们的药物组合物及其制备和使用方法。
-
公开(公告)号:US20070293491A1
公开(公告)日:2007-12-20
申请号:US11735302
申请日:2007-04-13
申请人: Cynthia Shafer , Annette Walter , Mika Lindvall , Thomas Gesner , Laura Doyle
发明人: Cynthia Shafer , Annette Walter , Mika Lindvall , Thomas Gesner , Laura Doyle
IPC分类号: A61K31/5375 , A61K31/44 , A61K31/445 , A61P35/00 , C07D239/20 , C07D295/00 , C07D241/02 , C07D213/02 , A61K31/496 , A61K31/506
CPC分类号: C07D403/04 , C07D401/14 , C07D403/14 , C07D405/14 , C07D471/04
摘要: New compounds capable of acting as CDC7 inhibitors are provided. The compounds are useful either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of CDC7 mediated diseases, such as cancer. The compounds have the Formula (I) or (II), where the values of the variables are defined herein.
摘要翻译: 提供能够作为CDC7抑制剂的新化合物。 该化合物可单独使用或与至少一种其它治疗剂组合用于预防或治疗CDC7介导的疾病例如癌症。 化合物具有式(I)或(II),其中变量的值在本文中定义。
-
公开(公告)号:US20050256157A1
公开(公告)日:2005-11-17
申请号:US11041191
申请日:2005-01-21
申请人: Thomas Gesner , Paul Barsanti , Stephen Harrison , Zhi-Jie Ni , Nathan Brammeier , Yasheen Zhou , Vincent Le
发明人: Thomas Gesner , Paul Barsanti , Stephen Harrison , Zhi-Jie Ni , Nathan Brammeier , Yasheen Zhou , Vincent Le
IPC分类号: A61K31/4709
CPC分类号: A61K31/4709
摘要: Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.
摘要翻译: 结构I和其盐,互变异构体,立体异构体及其混合物的化合物可用于抑制受试者中检查点激酶1,诱导细胞周期进程的方法和增加细胞凋亡的方法中的方法。 此类化合物可用于制备药物组合物,并可与DNA损伤剂联合使用。
-
-